Baillie Gifford & Co
QGENF

Baillie Gifford & Co’s QIAGEN NV QGENF Stock Holding History

Baillie Gifford & Co’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,592,794
Closed -$213M – 211
2016
Q4 		$213M Sell
7,592,794
-151,435
-2% -$4.24M 0.35% 62
2016
Q3 		$213M Sell
7,744,229
-74,199
-0.9% -$2.04M 0.33% 63
2016
Q2 		$171M Sell
7,818,428
-25,079
-0.3% -$547K 0.3% 63
2016
Q1 		$175M Buy
7,843,507
+59,651
+0.8% +$1.33M 0.31% 70
2015
Q4 		$215M Buy
7,783,856
+579,484
+8% +$16M 0.37% 57
2015
Q3 		$186M Buy
7,204,372
+259,100
+4% +$6.68M 0.36% 62
2015
Q2 		$172M Buy
6,945,272
+450,624
+7% +$11.2M 0.31% 66
2015
Q1 		$164M Buy
6,494,648
+190,260
+3% +$4.79M 0.31% 66
2014
Q4 		$148M Buy
6,304,388
+373,800
+6% +$8.77M 0.3% 65
2014
Q3 		$135M Buy
5,930,588
+112,900
+2% +$2.57M 0.3% 64
2014
Q2 		$142M Buy
5,817,688
+145,800
+3% +$3.56M 0.31% 63
2014
Q1 		$120M Buy
5,671,888
+94,688
+2% +$2M 0.28% 67
2013
Q4 		$133M Buy
5,577,200
+146,000
+3% +$3.48M 0.31% 64
2013
Q3 		$116M Buy
5,431,200
+558,500
+11% +$12M 0.29% 66
2013
Q2 		$97M Buy
+4,872,700
New +$97M 0.29% 69

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.7B AUM 32.92% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $5.31B AUM 55.82% 1-Year Est. Return

Baillie Gifford & Co's QGENF Position: Q1 2017 in Review

Baillie Gifford & Co sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 7,592,794 shares — an estimated $213M sold.

Baillie Gifford & Co first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $215M in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Baillie Gifford & Co reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Baillie Gifford & Co sold 7,592,794 QIAGEN NV shares in Q1 2017, an estimated $213M.
  • Baillie Gifford & Co first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Baillie Gifford & Co's QIAGEN NV position peaked at $215M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Baillie Gifford & Co's 13F filing for Q1 2017, filed 12 May 2017.